http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0001841-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8306dd772b17e73cd5060ef4bc67bede
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
filingDate 2000-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc74ccaeb65f49fe98ea750fc8935233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_267eb2cc0f4f728aee5c875cd9c08258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0435caf8449cabf36f51f30a6b4f7058
publicationDate 2002-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-0001841-A2
titleOfInvention Use of tranexamic acid for the preparation of a human fibrinogen composition
abstract Use of tranexamic acid for the preparation of a human fibrinogen composition. n The invention relates to the use of tranexamic acid for the preparation of a composition of human fibrinogen obtained from human plasma or by methods of recombinant or transgenic technology, with the simultaneous addition of human albumin, in order to reduce the solubilisation time when a physiologically compatible solvent is added, and relates also to the fibrinogen composition.
priorityDate 1999-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483213
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396423
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456144919
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456148107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID558311
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397731
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009195
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID85302
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID564
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100034206
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID247744
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24186

Total number of triples: 55.